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Abstract 
Introduction 
Cancer patients are at high risk of developing pressure ulcers at the end of life as a result of their 
underlying condition or cancer treatment. There are many guidelines which set out best practice 
with regards to end of life skin care. However, the complexity of palliative cancer care often means 
that it is challenging for nurses to make the appropriate person-centred decisions about of end life 
skin care.  This study seeks to explore the perceived importance that nurses place on different 
factors in their end of life skin care for cancer patients. The utility, face validity, and content validity 
of a prototype decision making tool for end of life skin care will also be evaluated. 
 
Methods and analysis 
A mixed method design will be used to gather data from primary and secondary care nurses working 
in different hospitals and local authority areas across Wales. Clinical vignettes will be used to gather 
qualitative and quantitative data from nurses in individual interviews. Qualitative data will be 
subject to thematic analysis and quantitative data will be subject to descriptive statistical analysis.  
Qualitative and quantitative data will then be synthesised, which will enhance the rigour of this 
study, and pertinently inform the further development of an end of life skin care decision making 
tool for cancer patients. 
 
Ethics and Dissemination 
Ethical approval to undertake the study has been granted by Cardiff University School of Healthcare 
Sciences Research Governance and Ethics Screening Committee. Informed consent will be obtained 
in writing from all the participants in this study. The results of this study will be disseminated 
through journal articles, as well as presentations at national and international conferences. We will 
also report our findings to Patient and Public Involvement groups with an interest in improving 
cancer care, palliative care as well as skin care. 
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Strengths and limitations 
1. Vignettes are an abstraction of reality, which are an effective way to explore ethically complex 
aspects of healthcare such as cancer patients’ end of life skin care   
2. Decisions based on a vignette may not reflect decisions in real life  
3. Clinical vignettes that describe typical cancer patients in clinical practice will be used to explore 
the impact of different factors on nurses’ end of life skin care related decision making. 
4. Our mixed method approach will provide an insight into the relative importance that nurses place 
on different factors in their end of life skin care decision making for cancer patients.  
5. This study will establish the face validity, content validity, and utility of a prototype end of life 
skin care decision making tool 
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Introduction 
Poor decision making by healthcare professionals about key aspects of skin care such as patient 
repositioning causes or contributes to pressure ulcer formation especially in patients approaching 
the end of life (1, 2).  Health care professionals often make challenging decisions about key aspects 
of end of life skin care such as whether or not to reposition a patient, which may inadvertently cause 
distress or discomfort in palliative care patients at the end of life  (1, 2).  Uncertainty about the goals 
of treatment, inappropriate presumptions or a desire to adhere to the prevailing clinical ethos in a 
given context can precipitate flawed skin care related decision-making concerning patients receiving 
palliative care (1-3). There are many guidelines (4-8) and publications (9, 10) which are designed to 
inform healthcare professionals’ decisions about end of life skin care.  These national and 
international guidelines (4-8) set out the prevailing consensus on best practice with regard to end of 
life skin care, which maintains skin integrity for as long as possible and facilitates a dignified death 
that is in line with the patient’s preferences. However, studies  (1, 2) from different contexts have 
identified that there can be conflict between the goals of palliative care, and pressure ulcer 
prevention, such as different perspectives on the frequency of patient repositioning, which 
contributes to poor decision making and results in the delivery of inappropriate end of life skin care. 
Patient care is delivered in healthcare systems that are inherently complex and adaptive, which can 
impinge on healthcare professionals’ ability to make decisions about patient care in line with the 
guidelines for best practice (11-13). The complexity of clinical practice often makes it challenging for 
individual healthcare professionals to gather and marshal pertinent information with an appropriate 
mental focus to make the best possible decisions about patient care (12, 13). Health professionals’ 
decision making at any point in the care trajectory is combination of judgements and decisions about 
the best course of action to maintain skin integrity with due respect for the patient’s preferences (2, 
14). Nurses can find it challenging to make appropriate patient centred decisions about end of life 
skin care due to uncertainty about the goals of care, as well as undue concerns about unsettling or 
causing distress to the person receiving care and their family (1, 2, 15). 
Patients receiving palliative care, especially those with cancer, are at high risk of developing pressure 
ulcers due to the underlying pathophysiology of the disease process, treatment side effects or 
therapeutic interventions (3, 16-18). Clinicians’ decisions about end of life patient care are 
influenced by a variety of factors relating to symptom management, the efficacy and/or acceptability 
of treatment interventions, the type/intensity of care that is required, as well as the wishes of the 
patient and family (19-22). Healthcare professionals are expected to make decisions that underpin 
the delivery of end of life care that is consistent with, and is a paramount factor regarding what the 
patient and their family consider to be a dignified death (23, 24).Empirical evidence from a variety of 
studies (25-28) demonstrates the utility of decision support tools and systems in fostering the 
consistent delivery of safe high-quality patient care. In a previous unpublished study (29),  we 
developed a prototype decision making tool with key principles and maxims that can be used as an 
informative guide concerning the appropriate the end of life skin care for cancer patients. The face 
and content validity, as well as the utility of this prototype end of life skin care decision making tool 
for cancer patients (29) needs to be established before the feasibility of integrating it into practice 
can be considered. 
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Aims  
The aims of this vignette study are to: 
1. Explore the perceived importance of different factors in nurses’ end of life skin care related 
decision-making for cancer patients  
2. Establish the utility, face and content validity of a prototype end of life skin care decision 
making tool  
3. Summarise the key factors to be integrated into a revised nurse decision-making tool for the 
end of life skin care of cancer patients  
 
Theoretical framework 
Skin care related decision making is influenced by a healthcare professional’s expertise, and ability to 
accurately assess the needs of the patient before selecting the most appropriate course of action (2, 
30).  Making decisions about skin care and end of life care is often challenging and complex due to 
the variety of individual, organisational, contextual, and patient related factors that have to be taken 
into account (2, 30-32). A significant consideration for any healthcare professional or person making 
a decision about some aspect of end of life care is how to deliver care which maximises the quality of 
life for the patient and facilitates a dignified and ‘good death’ (33, 34). However, the delivery of end 
of life skin care can be challenging because there is uncertainty about the extent to which some 
measures to maintain skin integrity such as regular repositioning can have unintended consequences 
such as distress or discomfort which are not compatible with a dignified ‘good death’(1, 2).  Defining 
what constitutes a good death is subjective as perceptions of dying well are socially and culturally 
mediated (32, 34). 
The term good death serves as an organising construct which can be understood in different ways 
depending on the socio-cultural, philosophical, and intellectual perspective that is adopted (35-37). 
Given that dying well and a good death are socially constructed, we have adopted a philosophical 
position that we feel is the most appropriate to inform the design of this study. This study will be 
undertaken in the critical realist paradigm with a realist ontology and abductive epistemology (38-
40). In line with our philosophical stance, this study will integrate empirical data with an interpretive 
outlook and a focus on theoretical abstraction. Data collection and analysis in this study will be 
informed by information processing theory (41, 42), which conceptualises decision making as being 
subject to the limits of a person’s memory, knowledge, and expertise. The use of information 
processing theory is congruent with the aim of this study as it focuses on understanding the basis of 
nurses’ end of life skin care related decision making with due recognition of their differing levels of 
knowledge and expertise.  
 
Methods and analysis 
Design 
We will conduct a concurrent mixed method study (38, 43, 44) that will use clinical vignettes to: 
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• Explore the perceived importance of different factors in nurses’ end of life skin care related 
decision-making for cancer patients  
• Establish the utility, face and content validity of a prototype end of life skin care decision 
making tool  
• Summarise the key factors to be integrated into a revised nurse decision-making tool for the 
end of life skin care of cancer patients  
 
Patient and Public Involvement 
This protocol was co-produced with patient and public involvement (PPI) in line with standards (45-
47) for best practice in research. The design of this study was informed by research priorities 
developed through wider patient and public involvement (PPI) in relation care (48), pressure ulcer 
prevention (49),  and end of life care (50). The PPI representative on the research team (CL-S) has 
also been involved in every aspect of the study including the formulation of the research question 
and study design. CL-S’ expertise as the family member of a cancer patient that received palliative 
care will underpin our analysis and interpretation of the data. The contribution of CLS is fundamental 
to this study as the overarching focus of palliative care, including end of life skin care, is on 
facilitating what the patient and their family consider to be a dignified death (23, 24).  We will 
discuss our preliminary results with national and regional cancer care PPI groups such as the North 
Wales Cancer Patient Forum (51), which functions as a voice for cancer patients and carers in a 
Welsh region. We will use the feedback from these PPI groups to inform our interpretation of the 
study results.  
 
Study population and sample 
We will recruit palliative, oncology tissue viability, and district nurses with experience of delivering 
end of life skin care to cancer patients from 19 hospitals and 8 local authorities in Wales. A stratified 
purposive sample (43, 44) of nurses across different professional bands will be recruited from a 
diverse range of clinical settings in order to generate the broadest possible insights. We intend to 
recruit 20-30 palliative, oncology, tissue viability, and district nurses but the exact number of 
participants will be determined by the point at which we have recruited a sufficiently diverse sample 
of participants with insight into end of life care from the study population to enhance the 
applicability of our results to nurses working in different clinical settings as well in line with best 
practice in mixed method research (38, 43, 44). The projected sample size for this study is in keeping 
with the number of participants that have been used to successfully develop and refine decision-
making tools in other studies (25, 52).  Potential participants will be sent details about our study 
together with a participant information sheet via email by the research and development 
department in each organisation. Nurses who are interested in taking part in the study will be asked 
to email or telephone the Chief Investigator (RS) to make suitable arrangements to get their written 
informed consent and gather data.  
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Data collection   
Semi-structured individual interviews will gather data about nurses’ decision-making concerning end 
of life skin care for cancer patients in a general sense and in relation to clinical vignettes (see Table 
1). Participants will be interviewed at a pre-arranged date and time that is convenient for the 
participants in a room away from the clinical setting to ensure privacy and confidentiality. The 
interviews which are expected to last for 30-45 minutes, will be digitally audio recorded and 
transcribed verbatim. 
  
Page 9 of 23 
 
Page | 9 
 
Table 1: Exemplar Vignette 
 
 
NB: The information in this vignette is hypothetical and any similarities to an actual patient are 
purely coincidental 
 
Name  Rhys  
Gender Male 
Age 70 
Medical History Lung cancer with metastatic spinal cord compression (T4 and T5)  
Ischaemic Heart Disease 
Chronic Obstructive Pulmonary Disease 
Catheterised 
 
Key information The patient has been deemed to be approaching the end of life and 
his care is being informed by national guidelines and quality standards 
for care of the dying 
This patient is not for cardio-pulmonary resuscitation 
The patient is on a syringe driver with cyclizine, midazolam and 
hyoscine 
He has a grade 2 pressure ulcer on sacrum and heels for dressing 
changes every three days 
The patient does not have any immediate family and he previously 
stated that he wishes to receive care that enhances his quality of life 
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Participants will be asked questions about their experiences about the delivery of end of life skin 
care and to rate the relative importance of different factors in decisions about this aspect of patient 
care using a numerical rating scale. Five vignettes and a prototype decision making tool will also be 
used to explore the participants end of life skin care related decision making. The interview 
schedule, items to be rated, and the clinical vignettes have all been informed by an earlier as yet 
unpublished study (29). Data will be gathered during the interviews with five vignettes as this has 
been shown to be the optimal number needed to gather data in other decision-making studies (53, 
54).  Vignettes are a good way of gathering data about different elements of healthcare 
professionals’ decision making (25, 53). The process of data collection is summarised in the flow 
diagram in Figure 1. 
 
In order to establish the face validity, content validity and utility of the prototype decision making 
tool, half of the participants will be given the prototype decision making tool alongside the vignettes 
and asked to decide how best to deliver end of life skin care in relation to each vignette. The 
participants that are asked to use the prototype decision making tool to inform their decisions about 
end of life skin care will be asked additional questions about its face validity, content validity, utility, 
and relevance. The other half of the participants will be given the vignettes and asked to decide how 
best to deliver end of life skin care using their clinical judgement. The participants who are asked to 
use their clinical judgement in reviewing the vignettes will be asked to explain how they made their 
decision, as well as what they think an end of life skin care decision making tool should look like, and 
to describe the elements that would enhance its face validity, content validity, utility and relevance.  
 
The use of two groups, one with a prototype decision making tool and the other without has been 
shown to be an effective way of ascertaining the content validity, face validity and utility of a 
decision-making tool in previous research (25). In order to ensure that the participants set out their 
views as honestly as possible, all of the participants will be informed that the focus of this study is 
not on the accuracy of their decision making about the delivery of skin care at the end of life; but the 
specific focus of this study is on how they make decisions. The relatively small number of 
participants in this exploratory mixed method study the extent to which we can make any 
meaningful statistical comparisons between the participants in the two groups. Therefore, we will 
look for differences in content validity, face validity and perceived utility of the prototype decision 
making tool between the participants in the two groups in our synthesis of qualitative and 
quantitative data, which can be further examined in subsequent research. 
 
Data analysis 
Our mixed method approach study (38, 43, 44) is designed to ascertain if the end of life skin care 
related decision-making factors identified in an earlier study (29), are pertinent and relevant to 
nurses working in other contexts through qualitative data, while the quantitative data will provide 
an insight into to their perceived relative importance of different factors. It is important to establish 
the factors that nurses take into account in end of life skin care related decision making as this may 
be linked to the reported shortcomings in patient care (1, 2). In line with our mixed method 
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approach (38, 43, 44) and the aims of this exploratory study, data will be analysed in a three step 
process, i.e.: 
1. Thematic analysis to provide an insight of the perceived important of different factors in 
nurses’ end of life skin care related decision making for cancer patients. The thematic analysis 
help to ascertain the utility, face and content validity of a prototype end of life skin care 
decision making tool  
 
2. Descriptive statistical analysis to generate descriptive summaries of the rankings of different 
factors that influence nurses end of life skin care related decision making  
 
3. Synthesis and interpretation to compare the numerical rankings and the narrative provided by 
each the participants about the relative importance of different factors in relation to end of life 
skin care related decision making. This in turn will enable us to summarise the key factors to be 
integrated into a revised nurse decision-making tool for the end of life skin care of cancer 
patients. 
 
This approach to data analysis and triangulation will enable us to achieve our aims in line with the 
underpinning philosophy of this study and will inform the further development of our prototype end 
of life skin care decision making tool for the end of life skin care of cancer patients. We will now set 
out each step of data analysis in more detail. 
 
Stage 1: Thematic analysis 
We will undertake thematic analysis (55, 56) of qualitative interview data and field notes informed 
by information processing theory (41, 42). Thematic analysis will be facilitated by the qualitative 
computer analysis package NVivo version 11.  Our thematic analysis of qualitative data generated is 
apt, as it generates insights into the themes and relationships that underpin the functioning, 
organisation or impact of the phenomena under investigation (43, 56).  Our thematic analysis will 
focus on the perceived importance of different factors in nurses’ end of life skin care related 
decision-making for cancer patients and establishing the face validity, content validity and utility of a 
prototype end of life skin care decision making tool. This focus in thematic analysis will enable us to 
summarise the key factors to be integrated into a revised nurse decision-making tool for the end of 
life skin care of cancer patients.  
Thematic analysis will be conducted in an iterative process that is set out in a linear format in Figure 
2. The iterative collection and thematic analysis of qualitative data will facilitate the development of 
theoretical and conceptual insights about nurses’ end of life skin care decision making which can be 
further developed as data collection progresses. Qualitative data generated in this study will be 
coded at the lowest level possible according to the tenets of thematic analysis to offset the danger 
of forcing data to fit codes and broad vague themes that do not relate to the topic of (43, 57). Initial 
data analysis will be undertaken by the Chief Investigator (RS) and independently reviewed by the 
other members of the research team to verify the primary researcher’s interpretation. Any 
differences of opinion with regards to the analysis or interpretation of qualitative data will be 
resolved by negotiation until a consensus is reached. The analysis of qualitative data will enable us 
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to explore the utility face and content validity of the prototype end of life skin care decision making 
tool. 
 
Reflexivity 
The researcher’s expertise influences the analysis and interpretation of qualitative data (44, 58). 
Reflexivity surfaces the impact of the researcher’s influence on qualitative research, which aids 
evaluation of the credibility and transferability of a study (43, 44, 58). Reflexive journals and team 
meetings also enhance the rigour of qualitative studies (43, 59). A reflexive journal will be kept by 
the researcher (RS) conducting the interviews and initial data analysis. The research team will also 
hold reflexive meetings where the impact of their differing perspectives on the interpretation of the 
qualitative data will be discussed. This is important as the members of our research term possess 
expertise in different areas, i.e. decision making (RS), patient and public perspective (CL-S) as well as 
cancer, palliative and supportive care (SA, CJ, JH). 
 
Stage 2: Descriptive statistical analysis  
We will conduct descriptive statistical analysis (60-63) of quantitative ranking data facilitated by SPSS 
version 23 (63-65) in order to describe and summarise the relative importance that the participants 
place on different factors. Participants will be asked to rate the relative importance of different end 
of life skin care related factors from an earlier study (29) with palliative care nurses working in a 
specialist cancer care setting, using a series of vignettes using a numerical rating scale (see Table 2). 
This rating exercise will generate quantitative data about the perceived relative importance of 
different end of life skin care related factors in nurse decision-making.  
Our descriptive statistical analysis (60-63) will generate descriptive summaries of the rankings that 
the participants place on different factors in nurses’ end of life decision making (see Table 2). This 
exploratory study has a small sample of participants, which makes it challenging to make any 
meaningful comparisons between the group of nurses who use clinical judgements and the nurses 
who use the prototype decision making tool. Consequently, the focus our descriptive quantitative 
analyses will seek to report any differences that merit exploration in a subsequent study with a 
larger and more representative sample. The descriptive statistical analyses of the numerical ratings 
given to different factors will identify those with the highest and lowest scores, thus providing an 
insight into their perceived relative importance.  In line with the tenets of descriptive analysis (60-
63), salient elements of the data will be presented in descriptive summaries in relation to each factor 
which will highlight the relative importance of different factors in relation to frequency, mean, 
median, and range. The data summaries for each individual factor will be presented in graphs that 
will be presented as appendices to the main paper. 
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Table 2: Key factors for end of life skin care decision making  
Adapted from Samuriwo et al. (29) 
What do you think is the relative importance of these different factors in nurses’ decision making 
about end of life skin care on a scale of 1-10 if one is the least important and 10 is the most 
important? (Please bear in mind that you can give the same rating to more than one factor or cue) 
 
 Factors  Rating   
1. (Nurse) Beliefs (about pressure ulcers and end of life skin care)  
2. (Nurse) Emotions & feelings  
3. (Nurse) Expertise & education  
4. Advice from colleagues  
5. (Nursing) Care co-ordination  
6. Clinical routine & medical devices  
7. (Pressure ulcer and end of life) Documentation  
8. (Pressure ulcer related) Quality assurance processes  
9. Severity of pressure ulcer  
10. (Nurse) Workload  
11. (Patient) Comfort  
12. (Patient) Dignity  
13. (Patient) Emotional wellbeing  
14. (Patient) Autonomy  
15. Patient preference   
16. (Patient) Physiological status  
17. Conversations (with patient’s family) & care delivery  
18. (Family) emotions and views  
19. (Family) Participation in care  
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Stage 3: Synthesis and interpretation 
In the final stage of our mixed method (43, 44) data analysis approach, the themes identified in the 
qualitative data will be integrated with the descriptive summaries generated from the quantitative 
ranking.  In this stage, rich qualitative data will be synthesised with the quantitative descriptive 
summaries of rankings in a coherent non-statistical discussion of the results on related hypotheses. 
Our approach to synthesis is congruent with the triangulation of qualitative and quantitative data in 
a concurrent mixed method study  (38, 43, 44).  
Our approach to synthesis is consistent with the principle of triangulation in concurrent mixed 
method research (38, 43, 44) which enhances the validity and completeness of the results. In other 
words, our synthesis of qualitative and quantitative data is in keeping with the principles of 
concurrent mixed method research (38, 43, 44) is designed to enable us to interpret all of the results 
from both sets of data in order to develop internally confirmed conclusions about the perceived 
relative importance of different factors in nurses end of life skin care related decision making. 
Triangulation of qualitative and quantitative data in this manner has been used in other mixed 
method studies (25, 66, 67) to develop and refine decision-making tools.  The synthesis of data in 
this manner will generate insights into the face validity, content validity and utility of the prototype 
decision making tool. The synthesis of qualitative and quantitative data will also enable us to 
summarise the key factors to be integrated into a revised nurse decision-making tool for the end of 
life skin care of cancer patients.  
We will also seek to establish if there are any patterns between the roles of the nurses who take part 
in this study and the ratings that they give to different factors. In other words, the rationale provided 
by the participants for their rankings in the qualitative data will be compared to their numerical 
rankings in the quantitative descriptive summaries. Triangulating qualitative and quantitative data in 
this manner during synthesis will highlight if there are any differences in the numerical rankings 
given by the participants as a result of their role or any other aspects of their practice that merit 
further exploration in subsequent research. The comparison between the qualitative and 
quantitative data relating to the rankings during synthesis will also provide us with a more detailed 
insight into the utility of the tool in their decision making.  
Synthesis of the two types of data in this manner has added importance because the extent to which 
people think that they make undertake decisions in a rational or intuitive manner often differs from 
how they make decisions especially about end of life care (31, 68, 69). Triangulating qualitative and 
qualitative data in mixed method studies provides a more complete internally confirmed insight into 
phenomenon of interest (38, 43, 44), which in this case is the face validity, content validity and utility 
of the prototype decision making tool. Simply put, combining the qualitative and quantitative data in 
this manner will highlight if there are any differences in the numerical rankings given by the 
participants as a result of their role or any other aspects of their practice that merit further 
exploration in subsequent research. 
 
Ethics and dissemination 
Ethical approval has been granted by the Cardiff University School of Healthcare Sciences Research 
Governance and Ethics Screening Committee. This study is sponsored by Cardiff University. The 
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protocol for this study was reviewed by Health and Care Research Wales (HCRW) (reference number 
18/HCRW/0014/IRAS project ID253097) and granted research governance approval by participating 
Welsh healthcare organisations.  
Written informed consent will be obtained from all participants in this study. Every participant will 
be provided with information about the study in a participant information sheet that will provide 
details about how they can raise any concerns about the study to the Cardiff University School of 
Healthcare Sciences Research Governance and Ethics Screening Committee. The participant 
information sheet will fully outline the potential benefits and burdens associated with study 
participation, and the informed consent process will ensure that this has been further understood. If 
any specific difficult issues or concerns related to care or their individual participant experiences are 
identified during the interviews, participants will be offered the opportunity to debrief after the 
interviews using a reflective approach to explore any issues relating to best practice in dealing with 
clinical experiences related to end of life care. Participants will also be signposted to support services 
for nurses provided by organisations such as the Royal College of Nursing. 
Our approach to dissemination will be multifaceted to ensure that the results of this study are 
shared with as many different people as possible. The results of this study will be reported to 
national and regional cancer care PPI groups.  We will also disseminate our results through 
presentations at local, national and international conferences as well as a paper submitted to a peer 
reviewed journal. We will share our provisional findings with national and regional cancer care PPI 
groups who will advise us on how best to present our findings with due considerations of the 
perspective of cancer patients and their families. We will also prepare a plain English summary of 
this study that will be disseminated to the public through charities and organisations that engage 
with the public in improving the quality of cancer and wound healing care. A press release of the 
study will be shared with the public via news, print and online media to raise awareness about our 
findings. 
 
Data storage and retention 
This study will adhere to research governance guidance and the law on data protection legislation 
with regards to the storage and retention of data. All study data will be anonymised and stored in 
university computers that are password protected or in locked cabinets in secure university 
buildings.  
 
Data sharing 
Data from this study will be available upon request in line with research governance policy and data 
protection legislation in response to a reasonable request. 
 
Discussion 
This exploratory vignette study will inform the further development of a decision-making tool that 
can be used in primary and secondary care to enable nurses to make the most appropriate end of 
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life skin care related decisions for cancer patients. Ultimately, this study will generate knowledge 
that can be used to inform and underpin efforts to improve nurses’ ability to deliver person-centred 
end of life skin care for cancer patients who are at high risk of developing pressure ulcers during the 
dying process (3, 16).  It will address some of the reported issues (1, 2, 15) relating to nurse decision 
making, which result in unwarranted variations or shortcomings in end of life skin care. 
This study will ascertain the relative importance of different factors that influence nurses’ end of life 
skin care related decision making for advanced cancer patients. This study will also explore the 
utility, face and content of a prototype decision making tool. Consequently, we contend that this 
study will address a key gap in knowledge and generate conceptual insights that can be used to 
improve the end of life skin care of cancer patients. This is the first study undertaken, to the best of 
our knowledge, that has sought to further develop an end of life skin care decision making tool 
specifically designed for use by nurses who look after cancer patients.  
In our view, this exploratory study will provide novel insights that can be used by nurses to 
consistently make the most appropriate decisions about the end of life skin care for cancer patients. 
Further research will be needed to establish the feasibility and acceptability of using the revised end 
of life skin care decision making tool by nurses, cancer patients, and their families. It is also 
envisaged that subsequent research will need to consider how a revised end of life skin related 
decision-making tool can be integrated into the wider organisation and delivery of palliative care to 
cancer patients. We anticipate that our study will have wider significance, and potentially an 
international impact, in informing efforts to improve end of life skin care for all patients. 
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Current status of the study 
Data collection began in April 2019 and results are expected in September 2020 
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Figure 1:  Data collection flow diagram 
 
 
 
  
All participants will be asked about their 
experiences of end of life skin care 
All participants will be asked their views about the relative 
importance of different factors and cues in end of life skin care 
related decision making 
Half of the participants will be 
asked to explain what end of life 
skin care related decisions they 
would make based on the 
information in each of the five 
vignettes and their clinical 
judgement  
  
Half of the participants will be 
asked to explain what end of life 
skin care related decisions they 
would make based on the 
information in each of the five 
vignettes and the prototype 
decision making tool  
  
Participants recruited  
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Figure 2: Flowchart for thematic analysis 
 
 
 
 
• Qualitative interview data digitally audio recorded
Initial phase
• 'In the moment’ interview field notes made and reflected on
Second phase 
• Interviews transcribed and field notes reviewed
Third phase
• Immersion in data (reading interview transcripts and field notes)
Fourth phase
• Forming first impressions
Fifth phase
• Development of concepts/themes/codes
Penultimate phase
• Refining and synthesising hypotheses/theory and  well as 
decision making tool
Final phase 
